Roztocil Elisa, Nicholl Suzanne M, Davies Mark G
Department of Cardiovascular Surgery, Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, Houston, TX 77030, USA.
Surgery. 2009 Jan;145(1):34-41. doi: 10.1016/j.surg.2008.08.001. Epub 2008 Sep 11.
Sphingosine-1-phosphate (S-1-P) is a bioactive sphingolipid released from activated platelets that stimulates migration of vascular smooth muscle cells (VSMC) in vitro. S-1-P will activate akt, which can regulate multiple cellular functions including cell migration. Akt activation is downstream of phosphatidylinositol 3'-kinase (PI3-K) and phosphoinositide-dependent protein kinase-1 (PDK1). The objective of this study was to examine the regulation of akt signaling during smooth muscle cell (SMC) migration in response to S-1-P.
Murine arterial SMC were cultured in vitro. Linear wound and microchemotaxis assays of migration in Boyden chambers were performed in the presence of S-1-P with and without an akt inhibitor (aktI). Assays were performed for PI3-K, PDK1, akt, and GSK3beta in the presence of various inhibitors and after transfection with the G beta gamma inhibitor beta ARK(CT).
S-1-P induced time-dependent PI3-K, PDK1, and akt activation. The migratory responses in both assays to S-1-P were blocked by aktI. Activation of akt and dephosphorylation of its downstream kinase, GSK3 beta, were inhibited by aktI. Inhibition of PI3-K with LY294002 significantly decreased activation of both PI3-K and akt. Inhibition of G beta gamma inhibited akt activation through a decrease in activation of both PI3-K and PDK1. Although inhibition of the ras with manumycin A had no effect, inhibition of rho with C3 limited activation of both PI3K and akt. PDK1 responses were unchanged by inhibition of GTPases. Inhibiting the generation of reactive oxygen species with N-acetylcysteine and of epidermal growth factor receptor with AG1478 inhibited PDK1 activation in response to S-1-P.
S-1-P-mediated migration is akt-dependent. S-1-P-mediated akt phosphorylation is controlled by a G beta gamma-dependent PI3-K activation, which requires the GTPase rho and G beta gamma. PDK1 activation requires G beta gamma-dependent generation of reactive oxygen species and epidermal growth factor receptor activation.
1-磷酸鞘氨醇(S-1-P)是一种从活化血小板释放的生物活性鞘脂,在体外可刺激血管平滑肌细胞(VSMC)迁移。S-1-P可激活Akt,Akt能调节包括细胞迁移在内的多种细胞功能。Akt的激活位于磷脂酰肌醇3'-激酶(PI3-K)和磷酸肌醇依赖性蛋白激酶-1(PDK1)的下游。本研究的目的是检测在平滑肌细胞(SMC)对S-1-P的迁移反应过程中Akt信号通路的调控情况。
体外培养小鼠动脉平滑肌细胞。在有或无Akt抑制剂(aktI)存在的情况下,用S-1-P进行线性划痕实验和Boyden小室中的微趋化性迁移实验。在存在各种抑制剂的情况下以及用Gβγ抑制剂βARK(CT)转染后,对PI3-K、PDK1、Akt和GSK3β进行检测。
S-1-P诱导PI3-K、PDK1和Akt呈时间依赖性激活。aktI可阻断两种实验中对S-1-P的迁移反应。aktI可抑制Akt的激活及其下游激酶GSK3β的去磷酸化。用LY294002抑制PI3-K可显著降低PI3-K和Akt的激活。抑制Gβγ可通过降低PI3-K和PDK1的激活来抑制Akt的激活。虽然用曼诺霉素A抑制ras没有作用,但用C3抑制rho可限制PI3K和Akt的激活。抑制GTP酶对PDK1的反应没有影响。用N-乙酰半胱氨酸抑制活性氧的产生以及用AG1478抑制表皮生长因子受体可抑制对S-1-P的PDK1激活。
S-1-P介导的迁移依赖于Akt。S-1-P介导的Akt磷酸化受Gβγ依赖性PI3-K激活的控制,这需要GTP酶rho和Gβγ。PDK1的激活需要Gβγ依赖性的活性氧产生和表皮生长因子受体激活。